Home/Filings/4/0001144204-10-025957
4//SEC Filing

FUERST THOMAS RICHARD 4

Accession 0001144204-10-025957

CIK 0001326190other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 9:58 PM ET

Size

10.9 KB

Accession

0001144204-10-025957

Insider Transaction Report

Form 4
Period: 2010-05-06
FUERST THOMAS RICHARD
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2010-05-06+20,00020,000 total
    Exercise: $1.38Exp: 2020-05-06Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]On May 6, 2010, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.38 per share.
  • [F2]The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.

Issuer

PHARMATHENE, INC

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001488331

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 9:58 PM ET
Size
10.9 KB